Lived experiences of women reporting fatigue during PARP inhibitor maintenance treatment for advanced ovarian cancer: A qualitative study
Journal Article
Overview
publication date
- January 1, 2021
has subject area
- Adnexal Diseases - Ovarian Neoplasms
- Aged
- Aged, 80 and over
- Antineoplastic Agents - Poly(ADP-ribose) Polymerase Inhibitors
- Endocrine System Diseases - Ovarian Neoplasms
- Enzyme Inhibitors - Poly(ADP-ribose) Polymerase Inhibitors
- Epidemiologic Measurements - Quality of Life
- Fatigue
- Female
- Female Urogenital Diseases - Ovarian Neoplasms
- Gonadal Disorders - Ovarian Neoplasms
- Humans
- Life - Quality of Life
- Middle Aged
- Neoplasms by Site - Ovarian Neoplasms
- Qualitative Research
- Social Sciences - Quality of Life
has restriction
- closed
Date in CU Experts
- January 25, 2021 5:27 AM
Full Author List
- Poort H; Fenton ATHR; Thompson E; Dinardo MM; Liu JF; Arch JJ; Wright AA
author count
- 7
citation count
- 6
published in
- Gynecologic Oncology Journal
Other Profiles
International Standard Serial Number (ISSN)
- 0090-8258
Electronic International Standard Serial Number (EISSN)
- 1095-6859
Digital Object Identifier (DOI)
Additional Document Info
start page
- 227
end page
- 233
volume
- 160
issue
- 1